MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

A

98.9

-4.01%↓

CHE

569.14

-0.87%↓

HQY

76.28

-4.98%↓

MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

A

98.9

-4.01%↓

CHE

569.14

-0.87%↓

HQY

76.28

-4.98%↓

MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

A

98.9

-4.01%↓

CHE

569.14

-0.87%↓

HQY

76.28

-4.98%↓

MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

A

98.9

-4.01%↓

CHE

569.14

-0.87%↓

HQY

76.28

-4.98%↓

MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

A

98.9

-4.01%↓

CHE

569.14

-0.87%↓

HQY

76.28

-4.98%↓

Search

MannKind Corp

Slēgts

SektorsVeselības aprūpe

4.6 -1.92

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

4.57

Max

4.79

Galvenie mērījumi

By Trading Economics

Ienākumi

-4.1M

7.4M

Pārdošana

6.7M

77M

P/E

Sektora vidējais

70.625

61.151

EPS

0.026

Peļņas marža

9.667

Darbinieki

403

EBITDA

-5.2M

19M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+104.69% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 7. maijs

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

1.6B

Iepriekšējā atvēršanas cena

6.52

Iepriekšējā slēgšanas cena

4.6

Ziņu noskaņojums

By Acuity

19%

81%

30 / 385 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bearish Evidence

MannKind Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 8. apr. 22:42 UTC

Galvenie tirgus virzītāji

Peabody Energy Shares Climb on Trump Executive Orders Boosting Coal Industry

2025. g. 8. apr. 22:35 UTC

Peļņas
Galvenie tirgus virzītāji

Cal-Maine Foods Shares Fall As Justice Dept Probes Egg Prices

2025. g. 8. apr. 21:30 UTC

Peļņas

Cal-Maine Foods Cooperating With Justice Dept Probe Into Egg Price Increases -- Update

2025. g. 8. apr. 21:21 UTC

Peļņas

Cal-Maine Foods Cooperating With Justice Dept Probe into Egg Price Increases

2025. g. 9. apr. 00:00 UTC

Top Ziņas

Trump's Tariffs Put Fed Chair Powell in a 'No-Win Situation' -- WSJ

2025. g. 8. apr. 23:45 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 8. apr. 23:45 UTC

Tirgus saruna

Nikkei May Fall Amid U.S. Tariff Uncertainty -- Market Talk

2025. g. 8. apr. 23:43 UTC

Tirgus saruna

Lithium Oversupply Weighs on Price Outlook -- Market Talk

2025. g. 8. apr. 23:43 UTC

Iegādes, apvienošanās, pārņemšana

Woolworths' Rivals Have Other Options to Source Ready Meals, ACCC Says

2025. g. 8. apr. 23:42 UTC

Tirgus saruna

Gold Falls on Possible Unwinding of Long Positions to Raise Cash -- Market Talk

2025. g. 8. apr. 23:42 UTC

Iegādes, apvienošanās, pārņemšana

Beak & Johnston Makes Ready Meals, Pastries for Wholesale, Retail

2025. g. 8. apr. 23:41 UTC

Iegādes, apvienošanās, pārņemšana

Woolworths' Acquisition Unlikely to Have Substantial Anti-Competitive Effect, ACCC Says

2025. g. 8. apr. 23:40 UTC

Iegādes, apvienošanās, pārņemšana

Australian Competition and Consumer Commission: Will Not Oppose Transaction

2025. g. 8. apr. 23:39 UTC

Iegādes, apvienošanās, pārņemšana

Australian Competition Regulator to Allow Woolworths' Acquisition of Beak & Johnston

2025. g. 8. apr. 23:21 UTC

Iegādes, apvienošanās, pārņemšana

U.S. Steel: $75 per Shr That the Ancora 'Plan' Proposes Is Really an Unrealistic, Distant Future Value Pipedream Rooted Firmly in Fiction >X

2025. g. 8. apr. 23:21 UTC

Iegādes, apvienošanās, pārņemšana

U.S. Steel: Stockholders Should Be Very Skeptical of Ancora's 'Plan' or That Their Nominees Could or Would Vigorously Fight for the Nippon Steel Deal >X

2025. g. 8. apr. 21:26 UTC

Top Ziņas

When Coffee Mate Made a 'White Lotus' Piña Colada Creamer, It Had No Idea How the Season Would End -- WSJ

2025. g. 8. apr. 21:26 UTC

Peļņas

Pfizer Stock's Fall to '97 Level Lifts Yield Near 8%. Dividend Looks Safe. -- Barrons.com

2025. g. 8. apr. 21:18 UTC

Iegādes, apvienošanās, pārņemšana

Peabody Energy: Remains in Conversation With Anglo Amer to Better Understand Impacts of Event, Preserving All Rights and Protections Under Purchase Agreements >BTU

2025. g. 8. apr. 21:18 UTC

Iegādes, apvienošanās, pārņemšana

Peabody Energy: Following Ignition Event Last Week at Anglo Amer's Moranbah North Mine, Reviewing Options Related to Acquisition of Steelmaking Coal Assets From Anglo Amer >BTU

2025. g. 8. apr. 21:06 UTC

Top Ziņas

Stocks Are in Turmoil, but Treasury Yields Are Stubbornly High -- Update

2025. g. 8. apr. 20:50 UTC

Top Ziņas

Harley-Davidson Seeks New CEO, Facing Sales Slump and Tariffs -- 3rd Update

2025. g. 8. apr. 20:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2025. g. 8. apr. 20:50 UTC

Tirgus saruna

Auto & Transport Roundup: Market Talk

2025. g. 8. apr. 20:40 UTC

Peļņas

BYD Stock Soars. It's Catching Up to Tesla in Yet Another Way. -- Barrons.com

2025. g. 8. apr. 20:28 UTC

Peļņas

Sandstorm Gold: Will Release 1Q Results on May 6 After Markets Close >SSL.T

2025. g. 8. apr. 20:28 UTC

Peļņas

Sandstorm Gold: During Three Mos Ended March 31, Realized Record Preliminary Revenue of $50.1M (20,316 Attributable Gold Equivalent Ounces and $42.8M in Rev for the Comparable Period in 2024) >SSL.T

2025. g. 8. apr. 20:28 UTC

Peļņas

Sandstorm Gold: Record Preliminary Total Sales, Royalties, Income From Other Interests of $54.1M for Three Mos Ended March 31 ($42.8M in Total Sales, Royalties, Income From Other Interests for Comparable Period in 2024) >SSL.T

2025. g. 8. apr. 20:28 UTC

Peļņas

Sandstorm Gold: During Three Mos Ended March 31, Sold Approximately 18,500 Attributable Gold Equivalent Ounces >SSL.T

2025. g. 8. apr. 20:14 UTC

Top Ziņas

U.S. Stocks Retreat as Optimism Over Trade Talks Fades -- WSJ

Salīdzinājums

Cenas izmaiņa

MannKind Corp Prognoze

Cenas mērķis

By TipRanks

104.69% augšup

Prognoze 12 mēnešiem

Vidējais 9.6 USD  104.69%

Augstākais 11 USD

Zemākais 9 USD

Pamatojoties uz 5 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi MannKind Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

5 ratings

5

Pirkt

0

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

4 / 4.777Atbalsts un pretestība

Īstermiņā

Strong Bearish Evidence

Vidējā termiņā

Weak Bearish Evidence

Ilgtermiņā

Bearish Evidence

Noskaņojums

By Acuity

30 / 385 Rangs Veselības aprūpe

Ziņu noskaņojums

Ļoti spēcīga liecība "buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par MannKind Corp

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes, and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults. The company's product pipeline also includes Tyvaso DPI (Treprostinil), an inhalation powder for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; MNKD-101, a nebulized formulation of clofazimine, for the treatment of severe chronic and recurrent pulmonary infections, including nontuberculous mycobacterial lung disease; MNKD-201, a dry-powder formulation of nintedanib, for the treatment of idiopathic pulmonary fibrosis (IPF). In addition, it has collaboration and license agreement with United Therapeutics Corporation for development, regulatory, and commercial activities of Tyvaso DPI; co-promotion agreement with Vertice Pharma to promote Thyquidity; and collaboration agreement with Thirona to evaluate the therapeutic for the treatment of pulmonary fibrosis. Further, the company has supply and distribution agreement with Biomm S.A. for the commercialization of Afrezza in Brazil; and license and distribution agreement with Cipla Ltd. for the marketing and distribution of Afrezza in India. MannKind Corporation was incorporated in 1991 and is headquartered in Danbury, Connecticut.